Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD

Chimeric antigen receptor (CAR) T cell therapy is an effective salvage therapy for pediatric relapsed B-cell acute lymphoblastic leukemia (B-ALL), yet is challenged by high rates of post-CAR relapse. Literature describing specific relapse patterns and extramedullary (EM) sites of involvement in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Schultz, Liora, Davis, Kara Lynn, Walkush, Ann, Baggott, Christina, Erickson, Courtney, Ramakrishna, Sneha, Aftandilian, Catherine, Lacayo, Norman, Nadel, Helen Ruth, Oak, Jean, Mackall, Crystal L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972424/
https://www.ncbi.nlm.nih.gov/pubmed/36849202
http://dx.doi.org/10.1136/jitc-2022-004851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972424/
https://www.ncbi.nlm.nih.gov/pubmed/36849202
http://dx.doi.org/10.1136/jitc-2022-004851

Ejemplares similares